Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Shanthi Rexaline

Teladoc Health Analysts Give Mixed Prognosis Following Q4 Earnings

Shares of Teladoc Health, Inc. (NYSE:TDOC) shares are lower after the telemedicine company issued below-consensus guidance for the first quarter.

The Teladoc Analysts: Needham analyst Ryan MacDonald reiterated a Buy rating on Teladoc shares and reduced the price target from $170 to $100.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.